Bentley Pharmaceuticals Reports $0.10 Diluted EPS on Record Revenues of $31.4 Million in the First Quarter of 2007

EXETER, N.H.--(BUSINESS WIRE)--Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today reported financial results for the three months ended March 31, 2007.